Cargando…
Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
INTRODUCTION: The aim of this retrospective clinical study was to assess, in the context of the recent evolution of systemic therapies, the potential effect of targeted therapies on overall survival (OS) of patients with metastatic clear-cell renal cell carcinoma (mccRCC) in daily practice. PATIENTS...
Autores principales: | Nerich, Virginie, Hugues, Marion, Paillard, Marie Justine, Borowski, Laëtitia, Nai, Thierry, Stein, Ulrich, Nguyen Tan Hon, Thierry, Montcuquet, Philippe, Maurina, Tristan, Mouillet, Guillaume, Kleinclauss, François, Pivot, Xavier, Limat, Samuel, Thiery-Vuillemin, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942215/ https://www.ncbi.nlm.nih.gov/pubmed/24600236 http://dx.doi.org/10.2147/OTT.S56370 |
Ejemplares similares
-
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
por: Mouillet, Guillaume, et al.
Publicado: (2018) -
Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study
por: CAUBET, MATTHIEU, et al.
Publicado: (2015) -
Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer
por: Calcagno, Fabien, et al.
Publicado: (2012) -
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
por: Calcagno, Fabien, et al.
Publicado: (2016) -
ATMP Environmental Exposure Assessment in European Healthcare Settings: A Systematic Review of the Literature
por: Damerval, Margaux, et al.
Publicado: (2021)